Albumin Nanovectors in Cancer Therapy and Imaging
- PMID: 31195727
- PMCID: PMC6627831
- DOI: 10.3390/biom9060218
Albumin Nanovectors in Cancer Therapy and Imaging
Abstract
Albumin nanovectors represent one of the most promising carriers recently generated because of the cost-effectiveness of their fabrication, biocompatibility, safety, and versatility in delivering hydrophilic and hydrophobic therapeutics and diagnostic agents. In this review, we describe and discuss the recent advances in how this technology has been harnessed for drug delivery in cancer, evaluating the commonly used synthesis protocols and considering the key factors that determine the biological transport and the effectiveness of such technology. With this in mind, we highlight how clinical and experimental albumin-based delivery nanoplatforms may be designed for tackling tumor progression or improving the currently established diagnostic procedures.
Keywords: albumin; cancer; drug delivery; nanomedicine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.Adv Mater. 2016 Dec;28(47):10557-10566. doi: 10.1002/adma.201600038. Epub 2016 Apr 25. Adv Mater. 2016. PMID: 27111654 Review.
-
Oligonucleotide-based theranostic nanoparticles in cancer therapy.Nanomedicine (Lond). 2016 May;11(10):1287-308. doi: 10.2217/nnm-2016-0035. Epub 2016 Apr 22. Nanomedicine (Lond). 2016. PMID: 27102380 Free PMC article. Review.
-
Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.Small. 2016 Sep;12(36):4936-4954. doi: 10.1002/smll.201600635. Epub 2016 May 6. Small. 2016. PMID: 27150247 Review.
-
2D Nanomaterials for Cancer Theranostic Applications.Adv Mater. 2020 Apr;32(13):e1902333. doi: 10.1002/adma.201902333. Epub 2019 Jul 28. Adv Mater. 2020. PMID: 31353752 Review.
-
Theranostic Probes for Cancer Imaging.Contrast Media Mol Imaging. 2017 Oct 18;2017:1863803. doi: 10.1155/2017/1863803. eCollection 2017. Contrast Media Mol Imaging. 2017. PMID: 29114172 Free PMC article. No abstract available.
Cited by
-
Interaction of miR-155 with Human Serum Albumin: An Atomic Force Spectroscopy, Fluorescence, FRET, and Computational Modelling Evidence.Int J Mol Sci. 2022 Sep 14;23(18):10728. doi: 10.3390/ijms231810728. Int J Mol Sci. 2022. PMID: 36142640 Free PMC article.
-
Contrast Agents Based on Human Serum Albumin and Nitroxides for 1H-MRI and Overhauser-Enhanced MRI.Int J Mol Sci. 2024 Apr 5;25(7):4041. doi: 10.3390/ijms25074041. Int J Mol Sci. 2024. PMID: 38612851 Free PMC article.
-
HSA-Binding Prodrugs-Based Nanoparticles Endowed with Chemo and Photo-Toxicity against Breast Cancer.Cancers (Basel). 2022 Feb 10;14(4):877. doi: 10.3390/cancers14040877. Cancers (Basel). 2022. PMID: 35205627 Free PMC article.
-
Recent advances in drug delivery of celastrol for enhancing efficiency and reducing the toxicity.Front Pharmacol. 2024 Feb 16;15:1137289. doi: 10.3389/fphar.2024.1137289. eCollection 2024. Front Pharmacol. 2024. PMID: 38434700 Free PMC article. Review.
-
Safety of Gold Nanoparticles: From In Vitro to In Vivo Testing Array Checklist.Pharmaceutics. 2023 Mar 31;15(4):1120. doi: 10.3390/pharmaceutics15041120. Pharmaceutics. 2023. PMID: 37111608 Free PMC article.
References
-
- Marchesan S., Kostarelos K., Bianco A., Prato M. The winding road for carbon nanotubes in nanomedicine. Mater. Today. 2015;18:12–19. doi: 10.1016/j.mattod.2014.07.009. - DOI
-
- Ciardelli G., Decuzzi P. Nanomedicine Advancing from Bench to Bedside: The Role of Polymeric Materials. Polym. Int. 2016;65:733. doi: 10.1002/pi.5140. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical